Understand the source comparison
GHRP-6 vs Other Growth Hormone Secretagogues: Critical Differences
GHRP-6 GHS-R1a (ghrelin receptor) Moderate (dose-dependent spike) Moderate (ghrelin-like effect) 20–30 minutes GH dynamics, metabolic studies, appetite regulation GHRP-2 GHS-R1a High (stronger GH spike than GHRP-6) Minimal GH secretion studies, anabolic signal
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GHRP-6
- GHS-R1a (ghrelin receptor)
- Moderate (dose-dependent spike)
- Moderate (ghrelin-like effect)
- 20–30 minutes
- GH dynamics, metabolic studies, appetite regulation
- GHRP-2
- GHS-R1a
- High (stronger GH spike than GHRP-6)
- Minimal
- GH secretion studies, anabolic signaling models
- Hexarelin
- Very high (most potent GH release)
- 70–90 minutes
- Cardiac function studies, neuroprotection models
- Ipamorelin
- Moderate (selective GH release)
- None (highly selective)
- 2 hours
- Selective GH studies, aging research
- MK-677
- Sustained (oral bioavailability)
- Moderate to high
- 4–6 hours
- Long-term GH exposure models, IGF-1 regulation
- GHRP-6 occupies a middle position among growth hormone secretagogues. Less potent than Hexarelin but more affordable and widely studied. Its moderate appetite stimulation makes it useful in metabolic research where ghrelin pathway activation is a study variable. GHRP-2 offers a cleaner alternative for researchers who want stronger GH release without appetite effects, while Hexarelin delivers the most pronounced GH spike but with a longer half-life that complicates dosing schedules.
- The choice between GHRP-6 and alternatives depends on the research question. Studies focused on appetite-GH interactions favor GHRP-6. Studies isolating GH's anabolic or metabolic effects favor GHRP-2 or Ipamorelin. Oral bioavailability studies require MK-677, which is orally active and sustains GH elevation for hours rather than minutes. None of these compounds differ based on acetate designation. The salt form is irrelevant to pharmacology.